{"release":"wpf-claim-checks","version":"1.6.0","checkedOn":"2026-11-22","verificationLabel":"AI-assisted source verification","humanReview":"none recorded","claim":{"id":"registered-trial-posted-results","claimWording":"If a peptide trial is registered, its results are public.","wordingKind":"representative","quoted":null,"title":"Trial registration versus posted results","peptides":["bpc-157","elamipretide","semaglutide","tirzepatide"],"aliases":["ClinicalTrials.gov","NCT number"],"topics":["interpretation"],"verdict":"overstated","plainAnswer":"Trial registration does not guarantee that results will be posted. In WPF’s sample, the completed BPC-157 supplement study NCT07752381 had no results posted on ClinicalTrials.gov as of the review date.","scope":{"population":"Registrations for four peptides that WPF followed: STEP 1, SURMOUNT-5, MMPOWER-3, the Barth syndrome trials, NCT02245620, NCT07275424 and the four BPC-157 registrations (NCT02637284, NCT07437547, NCT07752381, NCT07803250)","design":"Registry status and results fields on ClinicalTrials.gov, read on the date checked","boundary":"These registrations only. The results fields were read for the records named under strongest evidence; this check makes no statement about the results status of any other trial."},"strongest":[{"label":"ClinicalTrials.gov NCT03323749 (MMPOWER-3, terminated)","url":"https://clinicaltrials.gov/study/NCT03323749?tab=results","kind":"Registry record","population":"218 adults with primary mitochondrial myopathy","design":"Registered phase 3 randomized trial","locator":"Results first posted 2021-04-02; the registry gives that the double-blind part did not meet its primary endpoints as the reason for stopping."},{"label":"ClinicalTrials.gov NCT02245620 (older adults, completed)","url":"https://clinicaltrials.gov/study/NCT02245620?tab=results","kind":"Registry record","population":"41 adults aged 60 to 85","design":"Registered phase 2 trial","locator":"Results first posted 2020-06-23."},{"label":"ClinicalTrials.gov NCT07437547 (BPC-157, hamstring strain, recruiting)","url":"https://clinicaltrials.gov/study/NCT07437547","kind":"Registry record","population":"Adults with acute hamstring strain (planned)","design":"Registered phase 2 placebo-controlled trial","locator":"Record header: status Recruiting; no results posted."},{"label":"ClinicalTrials.gov NCT07752381 (BPC-157 supplement gummies, completed)","url":"https://clinicaltrials.gov/study/NCT07752381","kind":"Registry record","population":"40 participants (actual enrollment)","design":"Single-arm study, phase not applicable; first submitted 2026-08-03, after its 2025-11 completion; the registry does not mark it as an FDA-regulated drug or device trial","locator":"Registry record read 2026-11-22: status Completed (verified 2026-08); no results posted."}],"uncertain":["A recruiting trial is not expected to have results yet, so “no results” is not evidence of withholding.","NCT02637284 (BPC-157, phase 1) has unknown status and no results; whether it was completed is not known.","For NCT07752381 the registry gives no reason for the absence of results. It was registered after it finished and is not marked as an FDA-regulated drug or device trial, so this check draws no inference about why no results are posted.","Posted registry results are not peer reviewed and can differ from the publication in analysis method, as the SURMOUNT-1 disclosure shows."],"wouldChange":["A registry audit across all peptide trials, which would replace this small, hand-chosen sample."],"gaps":["WPF did not check every registered peptide trial. Results first-posted dates were read from the registry on 2026-11-14 and can change. The four BPC-157 records were read again on 2026-11-22."],"searchScope":{"searchedOn":"2026-11-22","sources":["ClinicalTrials.gov API v2"],"queries":["query.intr=BPC-157 -> 4 registrations, 0 with results (one completed: NCT07752381; three not completed: NCT02637284 unknown status, NCT07437547 recruiting, NCT07803250 not yet recruiting)","query.intr=elamipretide -> 25 registrations (two records opened for this check: NCT03323749 and NCT02245620)"],"found":"No results posted for any of the four BPC-157 registrations, including the completed NCT07752381. Results are posted for the two elamipretide records opened for this check (NCT03323749, terminated; NCT02245620, completed).","notSearched":["Other peptides","Registries other than ClinicalTrials.gov (for example EU CTR, ISRCTN)"]},"regulatory":null,"checkedOn":"2026-11-22","links":{"profiles":["/directory/bpc-157","/directory/elamipretide"],"films":[],"flagship":["https://www.worldpeptidefoundation.org/research/flagship/compare/weight-management#surmount-5-weight-72w"],"journeys":["/research/journey/elamipretide","/research/journey/semaglutide"],"teaching":[],"changes":["/research/changes#trial_result_posted"]},"extends1_0_0":true},"sha256":"953c466c79260025011bce6bcff32a886f7e59c76d62961cb156edba98d6b26d"}